Features

LAGOS (Capital Markets in Africa): Early agreements to purchase Covid-19 vaccines are beginning to pay off for the likes of Britain, the U.S., and Canada, but much of the world is waiting. Tempers are flaring over scarce supplies of the shots, with the European Union set to tighten rules on the export of vaccines in a move that risks a global protectionist battle between countries. And although there are ambitious efforts to ensure that the…

JOHANNESBURG (Capital Markets in Africa) — A new Covid-19 vaccine from Novavax Inc. was effective in big trials in the U.K. and South Africa, though its protective power appeared to be reduced in South Africa, where a worrisome mutation is prevalent. The results indicated that another highly potent vaccine could soon be available to help ameliorate the pandemic, in addition to existing vaccines from Pfizer Inc., Moderna Inc., and AstraZeneca Plc that are authorized in…

LAGOS (Capital Markets in Africa) — Royal Dutch Shell Plc faces the latest ruling in a long-running legal dispute with Nigerian farmers who say the energy giant is responsible for oil leaks that have polluted their villages. The case is the first in which a company and its foreign subsidiary have been tried in the Netherlands for allegedly breaching duty of care abroad, and it could have far-reaching implications for future suits brought against oil…

LAGOS (Capital Markets in Africa) — Sanctioned Israeli billionaire Dan Gertler can once again access the U.S. financial system after the Treasury Department approved authorization in the waning days of the Trump administration. The U.S. sanctioned Gertler and his companies in 2017 for allegedly corrupt mining and oil deals in the Democratic Republic of Congo, one of the world’s poorest countries. At the time, the Treasury said Gertler worked as a middleman between multinational companies…

LAGOS (Capital Markets in Africa) — Moderna Inc. said its vaccine will protect against two known variants of the Covid-19 virus, but it plans to start human studies of a booster shot for a strain from South Africa that may cause immunity to wane more quickly. In laboratory tests, Moderna’s vaccine produced antibody protection against the B.1.1.7 strain first identified in the U.K. at levels comparable with older forms of the virus. But against the…